Leptospirosis in Dogs: Clinical Signs, Diagnosis, and Zoonotic Risk

Abstract

Canine leptospirosis represents a globally distributed zoonotic disease caused by pathogenic spirochetes of the genus Leptospira. The disease manifests with multisystemic involvement characterized by acute kidney injury, hepatic dysfunction, pulmonary hemorrhage, and coagulopathy. This review synthesizes current knowledge regarding clinical pathophysiology, diagnostic methodologies including the microscopic agglutination test (MAT) and molecular detection assays, serovar distribution patterns, and zoonotic risk assessment within a One Health framework. Recent outbreak investigations and genomic surveillance data inform updated vaccination strategies and diagnostic algorithms for veterinary practitioners.

1. Etiology and Taxonomic Classification

Leptospira species belong to the order Spirochaetales, family Leptospiraceae. The genus comprises over 300 serovars organized into serogroups based on antigenic relatedness of the lipopolysaccharide (LPS) component. Pathogenic species include Leptospira interrogans, Leptospira kirschneri, Leptospira noguchii, Leptospira santarosai, Leptospira weilii, Leptospira alexanderi, Leptospira kmetyi, and Leptospira alstonii. Genomic analyses reveal substantial plasticity within the Leptospira pan-genome, with horizontal gene transfer contributing to serovar diversity and host adaptation [10]. The outer membrane contains lipoproteins such as LipL32, LipL41, and Loa22, which mediate adhesion to extracellular matrix components including fibronectin, laminin, and collagen type IV [12].

1.1 Serovar Epidemiology in Canine Populations

Serovar distribution exhibits marked geographic variation. In North America, serovars Pomona, Grippotyphosa, Bratislava, and Autumnalis predominate, while European isolates frequently belong to serogroups Icterohaemorrhagiae, Canicola, and Australis [3, 13]. A molecular surveillance study in Colombia identified Leptospira interrogans as the dominant species infecting domestic dogs, with serovar Canicola detected in 68 percent of positive samples [11]. Similarly, investigation of an outbreak in Los Angeles County, California, revealed Leptospira interrogans serovar Canicola as the causative agent, with evidence of dog-to-dog transmission in a congregate setting [3]. In the Yangtze River region of China, seroprevalence studies demonstrated exposure to serogroups Icterohaemorrhagiae, Sejroe, and Australis, with PCR confirmation of Leptospira interrogans and Leptospira kirschneri [13]. Serological surveys in Thailand identified pathogenic Leptospira species in both dogs and cats during routine neutering programs, highlighting the role of peri-domestic wildlife in maintenance cycles [9]. Comparative genomic analysis of Japanese isolates from humans, dogs, and wild animals demonstrated clonal relatedness across host species, supporting zoonotic transmission pathways [10].

2. Pathogenesis and Host-Pathogen Interactions

2.1 Mechanisms of Tissue Invasion

Following mucosal or percutaneous entry, leptospires disseminate hematogenously via a process facilitated by endotoxin-like LPS activity and secretion of metalloproteases that degrade basement membrane collagen. The organisms exhibit chemotaxis toward renal tubular epithelial cells, hepatic sinusoids, and pulmonary alveolar capillaries. Adhesion is mediated by surface-exposed proteins including LigA, LigB, and LenA/F, which bind host fibronectin and fibrinogen [10]. Complement resistance is conferred by acquisition of factor H and C4b-binding protein onto the leptospiral surface, enabling evasion of innate immunity.

2.2 Immunopathology of Acute Kidney Injury

Renal tropism results in tubular necrosis, interstitial nephritis, and glomerular thrombosis. The pathogenesis involves direct cytotoxic effects of leptospiral hemolysins (SphH, Sph2) and indirect immune-mediated damage through deposition of immune complexes in glomerular basement membranes. Upregulation of pro-inflammatory cytokines including interleukin-6, tumor necrosis factor-alpha, and monocyte chemoattractant protein-1 drives neutrophil infiltration and oxidative stress. Serum sialic acid concentrations correlate with disease severity and may serve as a biomarker of endothelial glycocalyx disruption and systemic inflammation [4].

2.3 Pulmonary Hemorrhage Syndrome

Pulmonary involvement manifests as alveolar hemorrhage, interstitial edema, and fibrin deposition. Serial computed tomography and functional respiratory assessments in naturally infected dogs reveal ground-glass opacities progressing to consolidation, with impaired gas exchange persisting beyond clinical recovery [1]. The pathophysiology involves leptospiral LPS-induced endothelial activation, upregulation of vascular endothelial growth factor, and dysregulation of angiopoietin-Tie2 signaling, resulting in increased vascular permeability. Coagulopathy secondary to hepatic synthetic dysfunction and disseminated intravascular coagulation exacerbates hemorrhagic diathesis.

3. Clinical Presentation

3.1 Acute Septicemic Phase

The incubation period ranges from 4 to 12 days. Initial signs include fever (39.5 to 41.0 degrees Celsius), lethargy, anorexia, and myalgia. Conjunctival suffusion without purulent discharge is a characteristic early finding. Petechial or ecchymotic hemorrhages on mucosal surfaces reflect thrombocytopenia and vasculitis.

3.2 Organ-Specific Manifestations

3.3 Atypical and Subclinical Presentations

Subclinical infections with persistent renal shedding occur in maintenance host populations. Seroprevalence studies in domiciled and stray dogs from subtropical Mexico demonstrated antibody titers against pathogenic Leptospira in 28.5 percent of sampled animals, with the majority lacking historical clinical signs [15]. Similarly, investigation of a Fulni-ô Indigenous community in Brazil revealed seropositivity in asymptomatic dogs, indicating endemic circulation [7]. These carrier states perpetuate environmental contamination and pose zoonotic risk to household contacts.

4. Diagnostic Methodologies

4.1 Microscopic Agglutination Test (MAT)

The MAT remains the reference standard for serological diagnosis. The assay detects agglutinating antibodies against a panel of live serovars representing local epidemiology. A fourfold rise in titer between acute and convalescent samples (collected 2 to 4 weeks apart) confirms active infection. Single titers of 1:800 or greater in unvaccinated dogs support presumptive diagnosis. Limitations include cross-reactivity among serogroups, inability to distinguish vaccine-induced from infection-induced antibodies for vaccinal serovars, and requirement for live antigen maintenance in reference laboratories.

4.2 Molecular Detection Assays

Polymerase chain reaction (PCR) targeting the lipL32 gene (encoding the major outer membrane lipoprotein LipL32) or the 16S rRNA gene provides rapid detection of pathogenic Leptospira DNA in blood (early acute phase) and urine (later phase and convalescent shedding). Quantitative PCR (qPCR) enables estimation of bacterial load, which correlates with disease severity and renal shedding intensity. Multiplex PCR panels incorporating internal amplification controls mitigate false-negative results due to PCR inhibitors in clinical specimens. The analytical sensitivity of validated assays reaches 10 to 100 genome equivalents per milliliter.

4.3 Serological Rapid Tests

Lateral flow immunoassays utilizing recombinant antigens such as Loa22 conjugated to gold nanoparticles offer point-of-care serodiagnosis with reported sensitivity of 89 percent and specificity of 94 percent compared to MAT in canine and bovine samples [12]. These assays detect immunoglobulin M (IgM) antibodies appearing 7 to 10 days post-infection. However, they cannot identify the infecting serovar and may yield false-positive results in recently vaccinated animals.

4.4 Diagnostic Algorithm

flowchart TD
    A["Clinical Suspicion: Acute febrile illness with renal/hepatic/pulmonary signs"] --> B{Vaccination History}
    B -->|Vaccinated > 2 weeks ago| C["MAT Panel: Include non-vaccinal serovars"]
    B -->|Unvaccinated or Unknown| D["MAT Panel: Comprehensive regional serovars"]
    C --> E["Acute Sample: MAT + Blood PCR"]
    D --> E
    E --> F{"MAT Titer >= 1:800 or PCR Positive"}
    F -->|Yes| G["Presumptive Diagnosis: Initiate Therapy"]
    F -->|No| H[Convalescent Sample at 14-21 Days]
    H --> I{Fourfold Titer Rise}
    I -->|Yes| G
    I -->|No| J[Consider Alternative Diagnoses]
    G --> K[Urine PCR at Day 7-10 for Shedding Assessment]
    K --> L[Environmental Decontamination and Zoonotic Risk Counseling]

4.5 Ancillary Laboratory Findings

Consistent clinicopathologic abnormalities include azotemia (creatinine > 2.5 mg/dL), hyperphosphatemia, elevated symmetric dimethylarginine (SDMA), increased alanine aminotransferase and alkaline phosphatase, hyperbilirubinemia, thrombocytopenia (< 150 x 10^9/L), prolonged coagulation times, and proteinuria with granular casts on urinalysis. Electrolyte derangements include hypokalemia (renal tubular dysfunction) and hyponatremia (syndrome of inappropriate antidiuretic hormone secretion).

5. Zoonotic Risk and One Health Implications

5.1 Transmission Dynamics

Dogs serve as both incidental hosts and maintenance reservoirs for specific serovars (notably Canicola). Transmission to humans occurs through direct contact with infected urine, contaminated water, or soil. The organism survives in moist, alkaline environments for weeks to months. Risk factors for human infection include occupational exposure (veterinary personnel, animal shelter workers), recreational water activities, and household contact with infected pets [8]. A study assessing infection risk in dogs exposed to clinical leptospirosis cases demonstrated secondary attack rates of 12 to 18 percent in co-housed animals, confirming efficient dog-to-dog transmission under conditions of close contact [8].

5.2 Environmental Drivers

Meteorological factors significantly influence leptospiral survival and transmission intensity. Increased rainfall, flooding events, and elevated ambient temperature correlate with outbreak occurrence in both human and canine populations [2]. Seasonal peaks in canine cases align with periods of high precipitation and moderate temperatures (15 to 25 degrees Celsius). Climate change projections suggest expansion of suitable habitats for leptospiral persistence into temperate regions.

5.3 Genomic Surveillance and Source Attribution

Whole-genome sequencing of isolates from dogs, humans, and wildlife enables high-resolution phylogenetic reconstruction of transmission networks. Core-genome multilocus sequence typing (cgMLST) and single-nucleotide polymorphism (SNP) analysis differentiate outbreak strains from background diversity. Comparative genomics of Japanese isolates revealed minimal genetic distance between canine and human strains of Leptospira interrogans serovar Icterohaemorrhagiae, supporting direct zoonotic transmission [10]. Molecular surveillance in Colombia identified identical sequence types in dogs and environmental water samples, implicating contaminated surface water as a common source [11].

6. Therapeutic Management

6.1 Antimicrobial Therapy

Doxycycline (5 mg/kg orally every 12 hours for 14 days) represents the antimicrobial of choice for elimination of leptospiremia and renal carriage. Intravenous penicillin derivatives (ampicillin 20 mg/kg every 6 hours) are indicated for initial management of severe cases with vomiting or impaired gastrointestinal absorption. Early initiation (within 72 hours of clinical onset) reduces mortality and duration of renal shedding. Jarisch-Herxheimer reactions may occur within 2 to 4 hours of first dose administration, manifesting as transient fever exacerbation, hypotension, and tachycardia.

6.2 Supportive Care

Aggressive intravenous fluid therapy with balanced crystalloids corrects dehydration, maintains renal perfusion, and promotes diuresis. Monitoring of central venous pressure and urine output guides fluid administration in oliguric patients. Renal replacement therapy (intermittent hemodialysis or continuous renal replacement therapy) is indicated for refractory uremia, volume overload, or severe electrolyte disturbances. Nutritional support via enteral feeding tubes addresses anorexia and catabolic state. Blood product transfusion (fresh frozen plasma, packed red blood cells) manages coagulopathy and anemia secondary to pulmonary hemorrhage.

7. Vaccination Strategies

7.1 Vaccine Composition and Immunogenicity

Commercial canine vaccines contain inactivated whole-cell bacterins of serovars Canicola, Icterohaemorrhagiae, Grippotyphosa, and Pomona (quadrivalent formulations). Bivalent vaccines (Canicola, Icterohaemorrhagiae) provide limited cross-protection. Immunogenicity is mediated primarily by anti-LPS IgG antibodies that prevent leptospiremia but do not consistently prevent renal colonization and shedding. Duration of immunity ranges from 12 to 15 months, necessitating annual revaccination in endemic areas.

7.2 Vaccination Protocols

Primary immunization consists of two doses administered 2 to 4 weeks apart starting at 8 to 9 weeks of age. Booster vaccination at 12 months completes the initial series. Annual revaccination is recommended for dogs with sustained exposure risk (rural environments, hunting, water contact). In outbreak settings, emergency vaccination of at-risk populations may reduce transmission intensity, although immunologic lag time (10 to 14 days) limits immediate protective effect.

7.3 Limitations and Adverse Events

Vaccine-induced MAT titers interfere with serological diagnosis for homologous serovars for up to 3 months post-vaccination. Acute hypersensitivity reactions (type I) occur at a rate of approximately 0.5 percent, with higher incidence in small-breed dogs receiving multiple concurrent vaccines. Premedication with antihistamines and corticosteroids mitigates reaction severity. Vaccine failure due to serovar mismatch remains a concern in regions where non-vaccinal serovars (Bratislava, Autumnalis, Copenhageni) circulate.

8. Prevention and Control Measures

8.1 Environmental Management

Rodent control reduces reservoir populations. Elimination of standing water, improved drainage, and restriction of access to wildlife-frequented areas decrease environmental contamination. Kennel and shelter protocols should include isolation of suspected cases, disinfection with quaternary ammonium compounds or 1:10 bleach solution, and use of personal protective equipment (gloves, gowns, face shields) by staff.

8.2 Surveillance and Reporting

Mandatory reporting of confirmed canine leptospirosis cases to veterinary public health authorities enables outbreak detection and implementation of control measures. Integration of canine surveillance data with human case reporting enhances One Health situational awareness. Serological surveys in sentinel populations (stray dogs, shelter admissions) provide early warning of serovar shifts.

9. Emerging Diagnostic Technologies

9.1 Next-Generation Sequencing Applications

Metagenomic sequencing of urine and blood samples enables direct detection and characterization of Leptospira without culture. Nanopore-based long-read sequencing facilitates assembly of complete genomes from clinical specimens, providing serovar prediction, virulence gene profiling, and antimicrobial resistance determinants in a single assay. Bioinformatic pipelines incorporating reference databases (PubMLST, NCBI RefSeq) automate taxonomic assignment and phylogenetic placement.

9.2 CRISPR-Based Detection

CRISPR-Cas12a systems targeting the lipL32 gene coupled with isothermal amplification (recombinase polymerase amplification) offer field-deployable molecular diagnostics with attomolar sensitivity. Lateral flow readout enables visual interpretation without instrumentation. These platforms are under validation for veterinary point-of-care use.

9.3 Host Biomarker Panels

Multiplex assays measuring neutrophil gelatinase-associated lipocalin (NGAL), cystatin C, and kidney injury molecule-1 (KIM-1) in urine and serum provide early detection of acute kidney injury prior to azotemia. Integration with inflammatory markers (C-reactive protein, serum amyloid A) and coagulation parameters (D-dimer, antithrombin III) generates prognostic scores for stratification of intensive care requirements.

10. Comparative Considerations

While this review focuses on canine leptospirosis, the pathogen exhibits broad host range including livestock, wildlife, and humans. Feline infection, historically considered rare, is increasingly recognized through molecular surveillance [9, 14]. Cross-species transmission at the human-animal-environment interface underscores the necessity for integrated surveillance and control programs. Computational models incorporating host mobility, environmental suitability, and pathogen genomics enhance predictive capacity for outbreak forecasting [6].

11. Conclusion

Canine leptospirosis remains a significant veterinary and public health challenge due to its multisystemic clinical presentation, diagnostic complexity, and zoonotic potential. Advances in molecular diagnostics, genomic epidemiology, and biomarker discovery are refining case detection, prognostic assessment, and source attribution. Vaccination remains the cornerstone of prevention, though serovar coverage gaps necessitate ongoing surveillance and vaccine reformulation. A One Health approach integrating veterinary, medical, and environmental health sectors is essential for effective control of this re-emerging zoonosis.

References

[1] Bringold C, Schweighauser A, Walther S et al. Serial evaluation of clinical, functional, and structural pulmonary changes in 10 dogs with leptospirosis. J Vet Intern Med. 2026. https://pubmed.ncbi.nlm.nih.gov/42224492/

[2] Hobson SJ, Zai B, Vyn CM et al. Impacts of meteorological factors on zoonotic infections in domestic cat and dog populations: A scoping review of international evidence. One Health. 2026. https://pubmed.ncbi.nlm.nih.gov/42211529/

[3] Randolph MW, Nally JE, Yoshimoto SK et al. Clinical and molecular characterization of an outbreak of leptospirosis in dogs from Los Angeles County, California, USA, 2021. J Clin Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42189535/

[4] Yaghoobpour T, Faraji M, Nazifi S. Serum Sialic Acid as a Biomarker of Inflammation and Infection: Insights From Veterinary Medicine. Vet Med Int. 2026. https://pubmed.ncbi.nlm.nih.gov/42148179/

[5] Patiño-Gómez S, Naranjo-Vargas LF, Aguirre-Acevedo DC et al. Epidemiological study of leptospiral interaction in bovine farms in rural areas of Colombia: A One Health approach. PLoS Negl Trop Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/42090421/

[6] Wei W, Jiao D, Dong X et al. Epidemiology and associated factors of human and canine leptospirosis in China: a systematic review and meta-analysis. Prev Vet Med. 2026. https://pubmed.ncbi.nlm.nih.gov/41864068/

[7] Galvão CMMQ, Leite DPSBM, Oliveira PRF et al. First serological investigation of Toxoplasma gondii, Neospora caninum, Leishmania infantum and Leptospira spp. in dogs from a Fulni-ô Indigenous community in Pernambuco, Brazil: a One Health perspective. Braz J Biol. 2026. https://pubmed.ncbi.nlm.nih.gov/41849483/

[8] Skinner VJ, Ward MP, Griebsch C. Risk of infection in dogs in contact with clinical canine leptospirosis cases. Aust Vet J. 2026. https://pubmed.ncbi.nlm.nih.gov/41814781/

[9] Thongdee M, Chaiwattanarungruengpaisan S, Paungpin W et al. Pathogenic Leptospira species identified in dogs and cats during neutering in Thailand. PLoS Negl Trop Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/41637464/

[10] Kakita T, Takabe K, Morita M et al. Genomic comparison of Leptospira interrogans isolated from humans, dogs, and wild and feral animals in Japan. Int J Med Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/41579465/

[11] Beltrán-Sánchez CA, Bettin AC, Castellanos-Romero K et al. Molecular surveillance of Leptospira infection in domestic dogs in Soledad, Northern Colombia. Vet Res Commun. 2026. https://pubmed.ncbi.nlm.nih.gov/41557245/

[12] Gautam H, Kumar BVS, Singh S et al. Evaluation of a recombinant Loa22-gold nanoparticle based lateral flow assay for the serodiagnosis of leptospirosis in canine and bovine. Arch Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/41524783/

[13] Ding Y, Zhang S, Zhang W et al. Seroprevalence and Molecular Epidemiology of Leptospira spp. Infecting Dogs in the Yangtze River Region of China. Transbound Emerg Dis. 2025. https://pubmed.ncbi.nlm.nih.gov/41383393/

[14] Jost HE, Henriksen ML, Hawley J et al. Evaluation of Leptospira species as a cause of endogenous uveitis in cats: a pilot study. J Feline Med Surg. 2026. https://pubmed.ncbi.nlm.nih.gov/41378760/

[15] Andrade-Silveira E, Segura-Correa JC, Ortega-Pacheco A et al. Seroprevalence of pathogenic leptospira in domiciled and stray dogs from subtropical Mexico. Vet Res Commun. 2025. https://pubmed.ncbi.nlm.nih.gov/41359150/

Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.